Intracranial stenting after failed endovascular thrombectomy is linked to improved outcomes in patients with acute ischemic ...

MINNEAPOLIS--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic ...

Chinese trials back yet more avenues to expand stroke therapy ...

Acute seizures occurring after pediatric ischemic stroke are strongly associated with an increased risk for subsequent poststroke epilepsy.

Timeliness of Emergency Care for Intracerebral Hemorrhage Compared With Acute Ischemic StrokeJournal: JAMA Network ...

"It's been over 4.5 hours since onset, so t-PA is not an option.""The infarction has already spread completely, so there is ...

Resolve Therapeutics, LLC, a clinical-stage biotechnology company developing nuclease-Fc fusion proteins designed to degrade pathogenic extracellular nucleic acids, today announced two e-posters ...

A retrospective cohort of 1,766 acute ischemic stroke patients found that a higher C-reactive protein-to-albumin ratio was ...

Whether endovascular therapy benefits patients with mild acute ischemic stroke from large-vessel occlusion involving the ...

Please provide your email address to receive an email when new articles are posted on . Acute ischemic stroke or stroke plus cervical artery dissection was associated with increased 1-year heart ...

Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...

DiaMedica Therapeutics Inc. announced that the 200th patient has been enrolled in its pivotal Phase 2/3 ReMEDy2 trial of DM199 (rinvecalinase alfa) in participants with acute ischemic stroke (AIS), ...